Worth reading
61In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Improvement
Direction inferred from the company’s description.Scale
45.3
Year-on-year change in operating profit (%)Wording
Conditional
How definitive the wording is.Results for this period
First quarter1 January 2026–31 March 2026ConsolidatedIFRSNet Sales413,224¥ millionYear on year +6.0%Progress 23.6%
Operating profit44,903¥ millionYear on year +45.3%Progress 24.7%
Ordinary income45,980¥ millionYear on year +45.6%Progress 24.9%
Net income attributable to owners of the parent30,999¥ millionYear on year +35.7%Progress 23.8%
The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
Net income per share¥68.53
Financial position at period-end
Total assets1,831,159¥ million
of which net assets 1,103,069 ¥ millionEquity ratio 58.6%vs. prior year-end +1.9pt
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Cash inflows and outflows
Operating-16,757
Investment+5,408
Financials-41,286
Net change-52,635
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Cash and cash equivalents at end of period¥274,840 million
Segment revenueHygiene and Living Care Business ¥128,972 million (YoY +3.6%), Health and Beauty Care Business ¥106,470 million (YoY +8.8%), Cosmetics Business ¥62,887 million (YoY +7.9%), Business Connected Business ¥8,496 million (YoY +3.1%), Chemicals Business 118,262 Millions of yen (including intersegment transactions) (YoY +5.6%)
Segment profitHygiene and Living Care Business ¥19,551 million, Health and Beauty Care Business ¥7,915 million, Cosmetics Business ¥2,085 million, Business Connected Business ¥93 million, Chemicals Business ¥3,602 million
Regional sales2,215 Hundreds of millions of yen (YoY +5.4%), 887 Hundreds of millions of yen (YoY +6.8%), 545 Hundreds of millions of yen (YoY +7.1%), 486 Hundreds of millions of yen (YoY +5.9%), 4,132 Hundreds of millions of yen (YoY +6.0%)
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥1,750,000 million (YoY +3.6%)
Operating profit¥182,000 million (YoY +11.3%)
Ordinary income¥185,000 million (YoY +8.9%)
Net income¥130,000 million (YoY +8.3%)
Annual Dividend Forecast154 Yen per share (comparison basis before taking the stock split into account) → 156 Yen per share (comparison basis before taking the stock split into account)（+1.3%）
Factors Behind Changes in Business Performance
Revenue increased 3.5% due to foreign exchange effects and 2.5% on a real basis (a 1.8% increase in volume and other factors and a 0.7% increase in prices). Profit in the global consumer care business increased due to higher sales volume and improved earning power, while profit in the Chemicals Business declined due to narrower margins caused by the timing gap in price revisions and weak demand in Europe and other regions. A gain on sale of ¥11.5 billion was recorded from the sale of land.
Disclosure regarding the going concern assumption
Not applicable.
Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 Yes見積りの変更 No修正再表示 Yes (comparative information has been restated through the retrospective application of IFRS 18)
Changes in the scope of consolidationNew Number of companies 0 / Company name Not disclosed / Excluded Number of companies 0 / Company name Not disclosed
Depreciation and amortization¥22,307 million (depreciation and amortization)
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingAvailable (for securities analysts and institutional investors)
Issued Shares at Period-End453,600,000 Shares
Treasury Shares at Period-End1,279,117 Shares
| Item | Details |
|---|---|
| Fiscal Period Classification | First quarter |
| Accounting standards | IFRS |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 January 2026–31 March 2026 |
| Net Sales | ¥413,224 million (YoY +6.0%) |
| Operating profit | ¥44,903 million (YoY +45.3%) |
| Ordinary income | ¥45,980 million (YoY +45.6%) |
| Profit attributable to owners of the parent | ¥30,999 million (YoY +35.7%) |
| Net income per share | ¥68.53 |
| Equity ratio | End of the current fiscal period 58.6 / End of previous period 56.7 |
| Total assets | ¥1,831,159 million |
| Net assets | ¥1,103,069 million |
| Cash flows from operating activities | ¥-16,757 million |
| Cash flows from investing activities | ¥5,408 million |
| Cash flows from financing activities | ¥-41,286 million |
| Cash and cash equivalents at end of period | ¥274,840 million |
| Full-year earnings forecast | Net Sales ¥1,750,000 million (YoY +3.6%) / Operating profit ¥182,000 million (YoY +11.3%) / Ordinary income ¥185,000 million (YoY +8.9%) / Net income ¥130,000 million (YoY +8.3%) |
| Annual Dividend Forecast | 154 Yen per share (comparison basis before taking the stock split into account) → 156 Yen per share (comparison basis before taking the stock split into account)（+1.3%） |
| Segment revenue | Hygiene and Living Care Business ¥128,972 million (YoY +3.6%), Health and Beauty Care Business ¥106,470 million (YoY +8.8%), Cosmetics Business ¥62,887 million (YoY +7.9%), Business Connected Business ¥8,496 million (YoY +3.1%), Chemicals Business 118,262 Millions of yen (including intersegment transactions) (YoY +5.6%) |
| Segment profit | Hygiene and Living Care Business ¥19,551 million, Health and Beauty Care Business ¥7,915 million, Cosmetics Business ¥2,085 million, Business Connected Business ¥93 million, Chemicals Business ¥3,602 million |
| Regional sales | 2,215 Hundreds of millions of yen (YoY +5.4%), 887 Hundreds of millions of yen (YoY +6.8%), 545 Hundreds of millions of yen (YoY +7.1%), 486 Hundreds of millions of yen (YoY +5.9%), 4,132 Hundreds of millions of yen (YoY +6.0%) |
| Depreciation and amortization | ¥22,307 million (depreciation and amortization) |
| Disclosure regarding the going concern assumption | Not applicable. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes Yes / Change in accounting estimate No / Restatement Yes (comparative information has been restated through the retrospective application of IFRS 18) |
| Changes in the scope of consolidation | New Number of companies 0 / Company name Not disclosed / Excluded Number of companies 0 / Company name Not disclosed |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Available (for securities analysts and institutional investors) |
| Issued Shares at Period-End | 453,600,000 Shares |
| Treasury Shares at Period-End | 1,279,117 Shares |
| Factors Behind Changes in Business Performance | Revenue increased 3.5% due to foreign exchange effects and 2.5% on a real basis (a 1.8% increase in volume and other factors and a 0.7% increase in prices). Profit in the global consumer care business increased due to higher sales volume and improved earning power, while profit in the Chemicals Business declined due to narrower margins caused by the timing gap in price revisions and weak demand in Europe and other regions. A gain on sale of ¥11.5 billion was recorded from the sale of land. |
Items this document does not state (8)
Operating MarginRevision to Earnings ForecastPayout ratioShareholder Return PolicyOrders received and order backlogImpairment lossBreakdown of extraordinary income (loss)Material subsequent events
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Higher profit was driven by strong performance in the global consumer care business, mainly in Japan, increased sales volume and improved earning power. In addition, land was sold as part of logistics optimization, resulting in a gain on sale of ¥11.5 billion. Meanwhile, profit in the Chemicals Business declined due to narrower margins caused by the timing gap in price revisions and weak demand in Europe and other regions.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.